Workflow
Here is Why Growth Investors Should Buy Calix (CALX) Now
ZACKS· 2025-07-25 17:46
Core Viewpoint - Investors are increasingly seeking growth stocks that demonstrate above-average growth potential, with Calix (CALX) being highlighted as a strong candidate due to its favorable growth metrics and Zacks Rank [1][2]. Group 1: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth being particularly attractive [4]. - Calix's projected EPS growth for the current year is 107.1%, significantly surpassing the industry average of 17.9% [5]. Group 2: Asset Utilization - The asset utilization ratio, or sales-to-total-assets (S/TA) ratio, is an important metric for assessing a company's efficiency in generating sales [6]. - Calix has an S/TA ratio of 0.94, indicating it generates $0.94 in sales for every dollar in assets, compared to the industry average of 0.58 [6]. Group 3: Sales Growth - Sales growth is another key indicator of a company's performance, with Calix expected to achieve a sales growth rate of 13.3% this year, outpacing the industry average of 5.7% [7]. Group 4: Earnings Estimate Revisions - Trends in earnings estimate revisions are correlated with stock price movements, with positive revisions being favorable [8]. - The current-year earnings estimates for Calix have increased by 166.7% over the past month, indicating strong upward momentum [9]. Group 5: Overall Positioning - Calix has achieved a Growth Score of A and a Zacks Rank of 2, positioning it well for potential outperformance in the growth stock category [11].
Here is Why Growth Investors Should Buy Ahold (ADRNY) Now
ZACKS· 2025-07-25 17:46
Core Insights - Growth investors seek stocks with above-average financial growth, but identifying such stocks can be challenging due to associated risks and volatility [1] - Ahold NV is currently recommended as a growth stock based on its favorable Growth Score and top Zacks Rank [2] Earnings Growth - Ahold's historical EPS growth rate is 2.7%, but projected EPS growth for this year is 11.2%, significantly higher than the industry average of 3.6% [4] Asset Utilization - Ahold has an asset utilization ratio of 1.8, indicating it generates $1.8 in sales for every dollar in assets, outperforming the industry average of 1.19 [5] Sales Growth - The company's sales are expected to grow by 12.9% this year, compared to an industry average of 0% [6] Earnings Estimate Revisions - There has been a positive trend in earnings estimate revisions for Ahold, with the Zacks Consensus Estimate for the current year increasing by 3.4% over the past month [8] Overall Positioning - Ahold has achieved a Zacks Rank 1 and a Growth Score of B, positioning it well for potential outperformance in the growth investment space [10]
MicroStrategy Rises 131% in a Year: Buy, Sell or Hold the MSTR Stock?
ZACKS· 2025-07-25 17:41
Key Takeaways MSTR shares rose 7.4% in a month, outperforming its sector but trailing MARA and RIOT stocks.Strategy now holds 607,770 bitcoins, adding 6,220 BTC in July for $739.8 million.Subscription revenue surged 62% to $37.1M, driven by Mosaic AI and rising demand for Strategy One cloud tools.MicroStrategy (MSTR) , doing business as “Strategy,” shares have appreciated 131% in the trailing 12 months, outperforming both the Zacks Computer - Software industry and Zacks Computer and Technology sector that h ...
Bureau Veritas SA (BVRDF) Q2 2025 Earnings Conference Call Transcript
Seeking Alpha· 2025-07-25 17:38
Hammond Power Solutions Inc. (OTCPK:HMDPF) Q2 2025 Earnings Call July 25, 2025 9:00 AM ET Company Participants Francois Chabas - Executive VP of Finance & Group CFO Hinda Gharbi - Chief Executive Officer Conference Call Participants Annelies Judith Godelieve Vermeulen - Morgan Stanley, Research Division Arthur David Truslove - Citigroup Inc., Research Division James Rowland Clark - Barclays Bank PLC, Research Division Suhasini Varanasi - Goldman Sachs Group, Inc., Research Division Operator Ladies and gentl ...
Why Gilead Sciences Stock Just Popped
The Motley Fool· 2025-07-25 17:37
Gilead stock is flashing "buy" in bright green letters.Biopharmaceuticals stock Gilead Sciences (GILD 2.70%) jumped 2.5% through 12:30 p.m. ET Friday after Needham & Co. upgraded the shares to a buy rating and slapped a $133 price target on the $116 stock.Key to the analyst's analysis is Gilead's new Yeztugo prescription medication for pre-exposure prevention of HIV-1. What Needham says about GileadCiting a survey of physicians, Needham reports in a note covered on The Fly this morning that the market for ...
Tesla Vs. Alphabet's Waymo: Which Robotaxi Company Is The Better Bet?
Seeking Alpha· 2025-07-25 17:36
Group 1 - The focus of PropNotes is on identifying high-yield investment opportunities for individual investors [1] - The company leverages a background in professional Prop Trading to simplify complex concepts and provide actionable insights [1] - All analyses produced by the company aim to assist investors in making informed market decisions, supported by expert research [1] Group 2 - The article expresses the author's personal opinions and discloses a beneficial long position in GOOG shares [2] - There is no compensation received for the article other than from Seeking Alpha, indicating an independent analysis [2] - Seeking Alpha clarifies that past performance does not guarantee future results and that the views expressed may not reflect the platform's overall stance [3]
Smurfit Westrock to Report Q2 Earnings: Here's What to Expect
ZACKS· 2025-07-25 17:36
Core Insights - Smurfit Westrock PLC (SW) is set to report its second-quarter 2025 results on July 30, 2025, before market open [1] - The company was formed by the merger of Smurfit Kappa and WestRock on July 5, 2024, and began reporting combined results from Q3 2024 [1] Financial Estimates - The Zacks Consensus Estimate for SW's Q2 2025 revenues is $7.92 billion, reflecting a 3.5% growth from Q1 2025 [2] - The earnings per share (EPS) estimate is 57 cents, indicating a decline from 73 cents in the previous quarter [2] - The consensus for earnings has increased by 9.5% over the past 60 days [2] Segment Performance - The Europe, MEA, and APAC segment is projected to generate revenues of $2.83 billion in Q2 2025, up from $2.58 billion in Q1 2025 [5] - The North America segment's revenue estimate is $4.62 billion, down from $4.67 billion in Q1 2025, with an adjusted EBITDA estimate of $753 million, a decrease from $785 million [6] - The LATAM segment's revenue estimate is $497 million, down from $513 million, while adjusted EBITDA is expected to rise to $124 million from $115 million [7] Market Dynamics - Demand for corrugated packaging and containerboard remains stable, driven by essential items like food and beverages, as well as e-commerce growth [4] - Increased costs for recovered fiber, labor, and distribution, particularly in Europe, are anticipated to pressure margins [4] - The company expects an adjusted EBITDA of $1.2 billion for Q2 2025 [4] Stock Performance - Smurfit Westrock's shares have increased by 3.8% over the past year, compared to the industry's growth of 28.8% [9]
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. (REPL)
GlobeNewswire News Room· 2025-07-25 17:36
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all persons or entities who purchased or otherwise acquired Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) securities between November 22, 2024 and October 21, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover damages for the Company’s investors under the f ...
First Citizens BancShares, Inc.(FCNCA) Q2 2025 Earnings Conference Call Transcript
Seeking Alpha· 2025-07-25 17:35
First Citizens BancShares, Inc.(NASDAQ:FCNCA) Q2 2025 Earnings Call July 25, 2025 9:00 AM ET Company Participants Craig Lockwood Nix - Chief Financial Officer Deanna W. Hart - Senior Vice President of Investor Relations Elliot Howard - Corporate Participant Frank Brown Holding - Chairman & CEO Marc Einerman - Managing Director Tom Eklund - Senior Vice President & Treasurer Conference Call Participants Bernard Von Gizycki - Deutsche Bank AG, Research Division Casey Haire - Unidentified Company Christopher Ed ...
Why Kinsale Capital Stock Popped, Then Dropped Today
The Motley Fool· 2025-07-25 17:32
Core Viewpoint - Kinsale Capital Group reported strong second-quarter earnings that exceeded analysts' expectations, but its share price has remained flat due to concerns over increased competition in the commercial property insurance market [2][3]. Group 1: Financial Performance - Kinsale's second-quarter earnings led to a 7% increase in share price initially, but it has since returned to flat levels [2]. - The company increased gross written premiums (GWPs) by 5% and grew earnings per share by 45% [6]. - Kinsale recorded a combined ratio of 76%, indicating profitability, and delivered a return on equity of 33% [6]. Group 2: Market Challenges - The largest insurance division, commercial property, experienced a 17% decline in GWPs compared to the previous year, attributed to heightened competition and lower pricing [3]. - Despite the decline in commercial property, the growth rates for the rest of Kinsale's business increased by 14%, showcasing the company's diversification strategy [5]. Group 3: Management Insights - Management acknowledged that GWP growth fell below the target of annualized increases between 10% and 20%, attributing this to standard cyclicality in the excess-and-surplus insurance industry [7]. - CEO Michael Kehoe emphasized that the company's loss reserves are conservatively stated, which, along with strong underwriting capabilities, positions Kinsale as a promising long-term investment [7].